Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor–Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202

PURPOSE: Adherence to aromatase inhibitor (AI) therapy for early-stage breast cancer is limited by AI-associated musculoskeletal symptoms (AIMSS). Duloxetine is US Food and Drug Administration approved for treatment of multiple chronic pain disorders. We hypothesized that treatment of AIMSS with dul...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Oncol
Main Authors: Henry, N. Lynn, Unger, Joseph M., Schott, Anne F., Fehrenbacher, Louis, Flynn, Patrick J., Prow, Debra M., Sharer, Carl W., Burton, Gary V., Kuzma, Charles S., Moseley, Anna, Lew, Danika L., Fisch, Michael J., Moinpour, Carol M., Hershman, Dawn L., Wade, James L.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2018
Assuntos:
ORIGINAL REPORTS
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5805479/
https://ncbi.nlm.nih.gov/pubmed/29136387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.74.6651
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares